Skip to main content
SpringerLink
Log in

Anwendung von neuen Neuroleptika bei nicht schizophrenen Erkrankungen

  • Conference paper
Neuroleptika bei nichtpsychotischen Störungen

  • 49 Accesses

Zusammenfassung

Die antipsychotische Wirkung der Neuroleptika beruht nach heutigem Kenntnisstand auf der pharmakologischen Blockade von Dopaminrezeptoren vom D2-Sub-typ (vgl. hierzu Müller 1998, in diesem Buch). Neuroleptika werden klinisch aber auch bei nicht schizophrenen Erkrankungen und bei nichtpsychotischen Syndromen erfolgreich angewendet, wobei der genaue pharmakologische Mechanismus für die Wirkung nicht abschließend geklärt ist. Es kann aber vermutet werden, daß auch hier die Dopaminrezeptorblockade eine wesentliche Rolle spielt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Angst J, Jaenicke U, Padrutt A, Scharfetter (1971) Ergebnisse eines Doppelblindversuchs von HF 1854 (8-Chlor-ll-[4-methyl-l-piperazinyl]-5H-dibenzo[b, e][l,4]diazepin) im Vergleich zu Levomepromazin. Pharmakopsychiatrie 4: 192–200.

    Article  CAS  Google Scholar 

  • Antonacci DJ, Swartz CM (1995) Clozapine treatment of euphoric mania. Ann Clin Psychiatry 7 (4): 203–206.

    Article  PubMed  CAS  Google Scholar 

  • Azou et al. (1996) Clozapine for the treatment of psychosis in Parkinson’s disease: a review. Acta Neurol Scand 94 (5): 329–336.

    Article  Google Scholar 

  • Baker RW, Chengappa KN, Baird JW, Steingard S, Christ MA, Schooler NR (1992) Emergence of obsessive compulsive symptoms during treatment with clozapine. J Clin Psychiatry 53 (12):439–442.

    PubMed  CAS  Google Scholar 

  • Banov MD, Zarate CA, Tohen M (1994) Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. J Clin Psychiatry 55: 295–300.

    PubMed  CAS  Google Scholar 

  • Barbini B, Scherillo P, Benedetti F, Crespi G, Colombo C, Smeraldi E (1997) Response to clozapine in acute mania is more rapid than that of chlorpromazine. Int Clin Psychopharmacol 12 (2): 109–112.

    Article  PubMed  CAS  Google Scholar 

  • Bonuccelli U, Ceravolo R, Maremmani C, Nuti A, Rossi G, Muratorio A (1994) Clozapine in Huntington’s chorea. Neurology 44 (5): 821–823.

    PubMed  CAS  Google Scholar 

  • Calabrese JR, Kimmel SE, Woyshville MJ, Rapport DJ, Faust CJ, Thompson PA, Meitzer HY (1996) Clozapine for treatment-refractory mania. Am J Psychiatry 153 (6): 759–764.

    PubMed  CAS  Google Scholar 

  • Cohen SA, Underwood MT (1994) The use of clozapine in a mentally retarded and aggressive population. J Clin Psychiatry 55 (10): 440–444.

    PubMed  CAS  Google Scholar 

  • Cole JO, Gardos G, Tarsy D (1980) Drug trials in persistent dyskinesia. In: Fann WE, Smith RC, Davis JM (eds) Tardive Dyskinesia, Research and Treatment. SP Medical and Scientific Books, New York, pp 419–427.

    Google Scholar 

  • Cook EH Jr, Olson K, Pliskin N (1996) Response of organic catatonia to risperidone. Arch Gen Psychiatry 53 (1): 82–83.

    PubMed  Google Scholar 

  • Dassa D, Kaladjian A, Azorin JM (1993) Clozapine in the treatment of psychotic refractory depression. Br J Psychiatry 163: 822–824.

    Article  PubMed  CAS  Google Scholar 

  • Diederich N, Keipes M, Graas M, Metz H (1995) Clozapine in the treatment of mental manifestations of Parkinson’s disease. Rev Neurol (Paris) 151 (4): 251–257.

    CAS  Google Scholar 

  • Dose (1992) Clozapin (Leponex) in der Behandlung der Huntington’schen Krankheit. In: Naber D, Müller-Spahn F (Hrsg) Clozapin - Pharmakologie und Klinik eines atypischen Neuroleptikums. Schattauer, Stuttgart, New York, S 121–126.

    Google Scholar 

  • Durif F, Vidailhet M, Assal F, Roche C, Bonnet AM, Agid Y (1997) Low-dose clozapine improves dyskinesias in Parkinson’s disease. Neurology 48 (3): 658–662.

    PubMed  CAS  Google Scholar 

  • Dwight MM, KeckPE Jr, Stanton SP, Strakowski SM, McElroy SL (1994) Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder. Lancet 344: 554–555.

    Google Scholar 

  • Factor SA, Freidman JH (1997) The emerging role of clozapine in the treatment of movement disorders. Mov Disord 12 (4): 483–496.

    Article  PubMed  CAS  Google Scholar 

  • Farde L, Nordstrøm AL (1992) PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients. Br J Psychiatry [Suppl] 17:30–33.

    Google Scholar 

  • Fava M (1997) Psychopharmacologic treatment of pathologic aggression. Psychiatr Clin North Am 20 (2): 427–451.

    Article  PubMed  CAS  Google Scholar 

  • Fischer PA, Baas A, Hefner R (1990) Treatment of parkinsonian tremor with clozapine. J Neural Transm Park Dis Dement Soc 2: 233–238.

    Article  CAS  Google Scholar 

  • Fischer PA (1992) Clozapin in der Behandlung des Parkinson-Tremors. In: Naber D, Müller-Spahn F (Hrsg.) Clozapin - Pharmakologie und Klinik eines atypischen Neuroleptikums. Schattauer, Stuttgart, New York, S 83–88.

    Google Scholar 

  • Frankenburg FR, Zanarini MC (1993) Clozapine treatment of borderline patients: a preliminary study. Compr Psychiatry 34: 402–405.

    Article  PubMed  CAS  Google Scholar 

  • Friedman JH, Koller WC, Lannon MC, Busenbark K, Swanson-Hyland E, Smith D (1997) Benztropine versus clozapine for the treatment of tremor in Parkinson’s disease. Neurology 48 (4): 1077–1081.

    PubMed  CAS  Google Scholar 

  • Furmaga KM, DeLeon OA, Sinha SB, Jobe TH, Gaviria M (1997) Psychosis in medical conditions: response to risperidone. Gen Hosp Psychiatry 19 (3): 223–228.

    Article  PubMed  CAS  Google Scholar 

  • Gerbino L, Shopsin B, Collora M (1980) Clozapine in the treatment of tardive dyskinesia: an interim report. In: Fann WE, Smith RC, Davis JM (eds) Tardive Dyskinesia, Research and Treatment. SP Medical and Scientific Books, New York, pp 475–489.

    Google Scholar 

  • Giron LT Jr, Koller WC (1996) Methods of managing levodopa-induced dyskinesias. Drug Saf 14 (6): 365–374.

    Article  PubMed  Google Scholar 

  • Harada T, Otsuki S (1986) Antimanic effect of zotepine. Clin Ther 8 (4): 406–414.

    PubMed  CAS  Google Scholar 

  • Jacobsen FM (1995) Risperidone in the treatment of affective illness and obsessive-compulsive disorder. J Clin Psychiatry 56 (9): 423–429.

    PubMed  CAS  Google Scholar 

  • Kapur S, Remington G (1996) Serotonin-Dopamine Interaction and Its Relevance to Schizophrenia. Am J Psychiatry 153 (4): 466–476.

    PubMed  CAS  Google Scholar 

  • Klimke A, Klieser E (1995) Das atypische Neuroleptikum Clozapin (Leponex) - Aktueller Kenntnisstand und neuere klinische Aspekte. Fortschr Neurol Psychiat 63: 173–195.

    Article  PubMed  CAS  Google Scholar 

  • Koek RJ, Kessler CC (1996) Probable Induction of Mania by Risperidone. J Clin Psychiatry 57 (4): 174–175.

    PubMed  CAS  Google Scholar 

  • Lang AE, Sandor P, Duff J (1995) Remoxipride in Parkinson’s disease: differential response in patients with dyskinesias fluctuations versus psychosis. Clin Neuropharmacol 18 (1): 39–45.

    Article  PubMed  CAS  Google Scholar 

  • Lecrubier Y, Boyer P, Turjanski S, Rein W (1997) Amisulpride versus imipramine and placebo in dysthymia and major depression. Amisulpride Study Group. J Affect Disord 43 (2): 95–103.

    Article  CAS  Google Scholar 

  • Lieberman JA, Saltz BL, Johns A et al. (1991) The effect of clozapine on tardive dyskinesia. Brit J Psychiatry 158: 503–510.

    Article  CAS  Google Scholar 

  • Lott RS, Kerrick JM, Cohen SA (1996) Clinical and Economic Aspects of Risperidone Treatment in Adults With Mental Retardation and Behavioral Disturbance. Psychopharmacol Bull 32 (4): 721–729.

    PubMed  CAS  Google Scholar 

  • McDougle CJ, Barr LC, Goodman WK, Pelton GH, Aronson SC, Anand A, Price LH (1995) Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder. Am J Psychiatry 152 (12): 1812–1814.

    PubMed  CAS  Google Scholar 

  • McElroy S, Keck PE, Pope HG Jr, Hudson JI, Faedda GL, Swann AC (1992) Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry 149: 1633–1644.

    PubMed  CAS  Google Scholar 

  • Mendis T, Mohr E, George A, Rusk IN, Gray P, Grimes JD (1994) Symptomatic relief from treatment-induced psychosis in Parkinson’s disease: an open-label pilot study with remoxipride. Mov Disord 9 (2): 197–200.

    Article  PubMed  CAS  Google Scholar 

  • Michals ML, ML Crismon, Roberts S, Childs A (1993) Clozapine response and adverse effects in nine brain-injured patients. J Clin Psychopharmacol 13: 198–203.

    Article  PubMed  CAS  Google Scholar 

  • Müller WE (1998) Pharmakologische Grundlagen der Therapie mit Neuroleptika außerhalb ihrer Anwendung bei Schizophrenen. In: Gaebel W, Klimke A (Hrsg.) Stellenwert der Neuroleptika bei der Behandlung nicht schizophrener Erkrankungen. Springer, Heidelberg, pp 15–30.

    Google Scholar 

  • Müller P, Heipertz R (1977) Zur Behandlung manischer Psychosen mit Clozapin. Fortschr Neurol Psychiat 45: 420–424.

    Google Scholar 

  • Privitera MR, Lamberti JS, Mahara K (1993) Clozapine in a bipolar depressed patient [letter]. Am J Psychiatry 150: 986.

    PubMed  CAS  Google Scholar 

  • Rabey JM, Treves TA, Neufeld MY, Orlov E, Korczyn AD (1995) Low-dose clozapine in the treatment of levodopa-induced mental disturbances in Parkinson’s disease. Neurology 45: 432–434.

    PubMed  CAS  Google Scholar 

  • Ranjan R, Meltzer HY (1996) Acute and long-term effectiveness of clozapine in treatment-resistant psychotic depression. Biol Psychiatry 40 (4): 253–258.

    Article  PubMed  CAS  Google Scholar 

  • Ratey JJ, Leveroni C, Kilmer D, Gutheil C, Swartz B (1993) The effects of clozapine on severely ill aggressive psychiatric inpatients in a state hospital. J Clin Psychiatry 54: 219–223.

    PubMed  CAS  Google Scholar 

  • Rich SS, Friedman JH, Ott BR (1995) Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson’s disease and other akinetic-rigid syndromes. J Clin Psychiatry 56 (12): 556–559.

    PubMed  CAS  Google Scholar 

  • Robertsson B, Karlsson I, Eriksson L, Olsson JO, Olofsson H, Jacobsson NO, Arnell G (1996) An atypical neuroleptic drug in the treatment of behavioural disturbances and psychotic symptoms in elderly people. Dementia 7 (3): 142–146.

    PubMed  CAS  Google Scholar 

  • Ruggieri S, De Pandis MF, Bonamartini A, Vacca L, Stocchi F (1997) Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson’s disease. Clin Neuropharmacol 20 (3): 204–209.

    Article  PubMed  CAS  Google Scholar 

  • Sandor P, Lang AE, Singal S, Angus C (1996) Remoxipride in the treatment of levodopa-induced psychosis. J Clin Psychopharmacol 16 (5): 395–399.

    Article  PubMed  CAS  Google Scholar 

  • Sajatovic M, Verbanac P, Ramirez LF, Meltzer HY (1991) Clozapine treatment of psychiatric symptoms resistant to neuroleptic treatment in patients with Huntington’s chorea. Neurology 41: 156.

    PubMed  CAS  Google Scholar 

  • Satterlee WG, Reams SG, Burns PR, Hamilton S, Tran PV, Tollefson GD (1995) A clinical update on olanzapine treatment in schizophrenia and in elderly Alzheimer’s disease patients. Psychopharmacol Bull 31: 534-z.

    Google Scholar 

  • Simpson GM, Lee JH, Shrivastava (1978) Clozapine in tardive dyskinesia. Psychopharmacology 56 (1): 75–80.

    Article  PubMed  CAS  Google Scholar 

  • Singh AN, Catalan J (1994) Risperidone in HIV-related manic psychosis [letter]. Lancet 344: 1029–1030.

    Article  PubMed  CAS  Google Scholar 

  • Sipahimalani A, Masand PS (1997) Use of risperidone in delirium: case reports. Ann Clin Psychiatry 9 (2): 105–107.

    PubMed  CAS  Google Scholar 

  • Small JG, Milstein V, Marhenke JD (1987) Treatment outcome with clozapine in tardive dyskinesia neuroleptic sensitivity and treatment-resistant psychosis. J Clin Psychiatry 48: 263–267.

    PubMed  CAS  Google Scholar 

  • Spivak B, Mester R, Abesgaus J, Wittenberg N, Adlersberg S, Gonen N, Weizman A (1997) Clozapine Treatment for Neuroleptic-Induced Tardive Dyskinesia, Parkinsonism, and Chronic Akathisia in Schizophrenic Patients. J Clin Psychiatry 58 (7): 318–322.

    Article  PubMed  CAS  Google Scholar 

  • Suppes T, McElroy SL, Gilbert J, Dessain EC, Cole JO (1992) Clozapine in the treatment of dysphoric mania. Biol Psychiatry 32 (3): 270–280.

    Article  PubMed  CAS  Google Scholar 

  • Suppes T, Phillips KA, Judd CR (1994) Clozapine treatment of nonpsychotic rapid cycling bipolar disorder. Biol Psychiatry 36: 338–340.

    Article  PubMed  CAS  Google Scholar 

  • Steinert T, Schmidt-Michel PO, Kaschka WP (1996) Considerable improvement in a case of obsessive-compulsive disorder in an emotionally unstable personality disorder, borderline type under treatment with clozapine. Pharmacopsychiatry 29 (3): 111–114.

    Article  PubMed  CAS  Google Scholar 

  • Thorpe L (1997) The treatment of psychotic disorders in late life. Can J Psychiatry 42 (Suppl. 1): 19 S-27 S.

    Google Scholar 

  • Tohen M, Zarate CA, Centorrino F, Hegarty JI, Froeschl M, Zarate SB (1996) Risperidone in the Treatment of Mania. J Clin Psychiatry 57 (6): 249–253.

    PubMed  CAS  Google Scholar 

  • Van den Borre, Vermote R, Buttiëns M, Thiry P, Dierick G, Geutgens J, Sieben G, Heylen S (1993) Risperidone as add-on therapy in behavioural disturbances in mental retardation: a double-blind placebo-controlled cross-over study. Acta Psychiatr Scand 87: 161–171.

    Article  Google Scholar 

  • van Vugt JP, Siesling S, Vergeer M, van der Velde EA, Roos RA (1997) Clozapine versus placebo in Huntington’s disease: a double blind randomised comparative study. J Neurol Neurosurg Psychiatry 63 (1): 35–39.

    Article  PubMed  Google Scholar 

  • Vieta E, Gasto C, Escobar R (1995) Treatment of dysphoric mania with risperidone. Hum Psychopharmacol Clin Exp 10: 491–492.

    Google Scholar 

  • Vyncke J (1974) The treatment of behavior disorders in idiocy and imbecility with clozapine. Pharmacopsychiatry 7: 225–229.

    Article  CAS  Google Scholar 

  • Wagner ML, Defìlippi JL, Menza MA, Sage JI (1996) Clozapine for the treatment of psychosis in Parkinson’s disease: chart review of 49 patients. J Neuropsychiatry Clin Neurosci 8 (3): 276–280.

    PubMed  CAS  Google Scholar 

  • Wolters EC, Jansen EN, Tuynman-Qua HG, Bergmans PL (1996) Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson’s disease. Neurology 47 (4): 1085–1087.

    PubMed  CAS  Google Scholar 

  • Zarate CA, Tohen M, Baldessarini RJ (1995) Clozapine in Severe Mood Disorder. J Clin Psychiatry 56 (9): 411–416.

    PubMed  Google Scholar 

  • Zarate CA Jr, Baldessarini RJ, Siegel AJ, Nakamura A, McDonald J, Muir-Hutchinson LA, Cherkerzian T, Tohen M (1997) Risperidone in the elderly: a pharmacoepidemiologic study. J Clin Psychiatry 58 (7): 311–317.

    Article  PubMed  CAS  Google Scholar 

  • Zimnitzky BM, DeMaso DR, Steingard RJ (1996) Use of Risperidone in Psychotic Disorder following Ischemic Brain Damage. J Child Adolesc Psychopharmacol 6 (1): 75–78.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheinische Kliniken Düsseldorf, Psychiatrische Klinik der Heinrich-Heine-Universität, Bergische Landstraße 2, 40629, Düsseldorf, Germany

    Dr. Priv. Doz. med. A. Klimke

Authors
  1. Dr. Priv. Doz. med. A. Klimke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Rheinische Kliniken Düsseldorf, Pyschiatrische Klinik der heinrich-heine-Universität, Bergische Landstraße 2, D-40629, Düsseldorf, Germany

    Wolfgang Gaebel  & Ansgar Klimke  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin heidelberg

About this paper

Cite this paper

Klimke, A. (1999). Anwendung von neuen Neuroleptika bei nicht schizophrenen Erkrankungen. In: Gaebel, W., Klimke, A. (eds) Neuroleptika bei nichtpsychotischen Störungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59977-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59977-4_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-64940-3

  • Online ISBN: 978-3-642-59977-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation